Skip to content
← Back to this collection

PUBLICATIONS · 22715121

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2012 Aug 23
First author
Iland HJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2012 Aug 23;120(8):1535-6. doi: 10.1182/blood-2012-07-439547.
    note
    Source null
    related pmid
    22918418
    relationship
    Comment in

Authors and identifiers

  1. name
    Iland HJ
    type
    Author
  2. name
    Bradstock K
    type
    Author
  3. name
    Supple SG
    type
    Author
  4. name
    Catalano A
    type
    Author
  5. name
    Collins M
    type
    Author
  6. name
    Hertzberg M
    type
    Author
  7. name
    Browett P
    type
    Author
  8. name
    Grigg A
    type
    Author
  9. name
    Firkin F
    type
    Author
  10. name
    Hugman A
    type
    Author
  11. name
    Reynolds J
    type
    Author
  12. name
    Di Iulio J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Iland HJ
    type
    Author
  2. name
    Bradstock K
    type
    Author
  3. name
    Supple SG
    type
    Author
  4. name
    Catalano A
    type
    Author
  5. name
    Collins M
    type
    Author
  6. name
    Hertzberg M
    type
    Author
  7. name
    Browett P
    type
    Author
  8. name
    Grigg A
    type
    Author
  9. name
    Firkin F
    type
    Author
  10. name
    Hugman A
    type
    Author
  11. name
    Reynolds J
    type
    Author
  12. name
    Di Iulio J
    type
    Author
bibliography ids
  1. nci-bib-29b98473c116192e045016a6
book metadata
content sha256
89ce9148e99d75d9707b9b7b34fdddaa30d7015d313fe400f66ab160606af7cb
document type
citation
dois
  1. 10.1182/blood-2012-02-410746
electronic publication date
display
2012 Jun 19
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22715121
immutable id
pubmed:22715121@89ce9148e99d75d9707b9b7b34fdddaa30d7015d313fe400f66ab160606af7cb
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
8
name
Blood
nlm unique id
7603509
pages
1570-80; quiz 1752
volume
120
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2012 Aug 23;120(8):1535-6. doi: 10.1182/blood-2012-07-439547.
    note
    Source null
    related pmid
    22918418
    relationship
    Comment in
outcomes validated
false
pmid
22715121
provenance
batch id
c95be1d0b8cf19942816
provider
NCBI PubMed ESummary
record sha256
78863a17b7cd2920c3b83d7f999b115407e3b75d3f5bd43f1864c57dd8438d2f
response sha256
a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
retrieved at
2026-09-09T23:46:47.691937+00:00
publication date
display
2012 Aug 23
precision
day
year
2012
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22715121/
title
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).

Preserved source evidence · Not medical advice